Authors: Dietrich, ES Schubert, B Ebner, W Daschner, F

Citation: Es. Dietrich et al., Cost efficacy of tazobactam/piperacillin versus imipenem/cilastatin in thetreatment of intra-abdominal infection, PHARMACOECO, 19(1), 2001, pp. 79-94

Authors: Dietrich, ES

Citation: Es. Dietrich, Comment: cost-effectiveness of macrolides in lower respiratory tract infections - Authors' reply, ANN PHARMAC, 34(10), 2000, pp. 1206-1207

Authors: Dietrich, ES

Citation: Es. Dietrich, Cost-effectiveness of macrolides in lower respiratory tract infections, ANN PHARMAC, 33(10), 1999, pp. 1125-1126

Authors: Dietrich, ES Patz, E Frank, U Daschner, FD

Citation: Es. Dietrich et al., Cost-effectiveness of ceftazidime or imipenem/cilastatin versus ceftriaxone plus aminoglycoside in the treatment of febrile episodes in neutropenic cancer patients in Germany, INFECTION, 27(1), 1999, pp. 23-27